Filing Details
Regen BioPharma Inc (OTC:RGBP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 17, 2026.
The Healthcare company reported Q0 revenue of .
10q filedOTC:RGBP
Regen BioPharma Inc (RGBP) Files Quarterly Report for Q0
Regen BioPharma Inc (OTC:RGBP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 17, 2026.
At publication ·
What changed
Regen BioPharma Inc (OTC:RGBP) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Regen BioPharma Inc (OTC:RGBP) filed its quarterly report (Form 10-Q) with the SEC on August 17, 2026.
- The company's stock trades at $0.00 with a market capitalization of $189.3K, indicating a very small-cap healthcare company.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this filing summary.
Market Context
Regen BioPharma Inc's stock currently trades at $0.00 with a market capitalization of $189.3K.
The 10-Q provides Regen BioPharma Inc's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Regen BioPharma Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RGBP Stock Page
Frequently Asked Questions
Where can I read RGBP's SEC filings?
Browse all filings on our RGBP SEC filings page.
What types of SEC filings does Regen BioPharma Inc file?
Public companies like Regen BioPharma Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.